Streptococcus pyogenes forms a substance which has a toxic action on the isolated frog's heart. The action is not a direct one because a single application of the preparation of toxin, although without obvious effect, causes the heart to become sensitive to a second application of the toxin (1). It has been shown that the sensitizing action of the first application is accompanied by the release from the heart tissues of a protective substance or "toxin inhibitor" (2). The toxin inhibitor is characterized by its capacity to prevent the cardiac action of the toxin (systolic contracture) and by its capacity to neutralize the lethal factor present in the streptococcal preparation employed (2). There is reason to believe that the streptococcal toxin causing these effects is similar to, if not identical with streptolysin O, the oxygen-labile hemolysin of streptococci. Proof of identity must await preparation of the material in pure form.
Streptococcus pyogenes forms a substance which has a toxic action on the isolated frog's heart. The action is not a direct one because a single application of the preparation of toxin, although without obvious effect, causes the heart to become sensitive to a second application of the toxin (1) . It has been shown that the sensitizing action of the first application is accompanied by the release from the heart tissues of a protective substance or "toxin inhibitor" (2) . The toxin inhibitor is characterized by its capacity to prevent the cardiac action of the toxin (systolic contracture) and by its capacity to neutralize the lethal factor present in the streptococcal preparation employed (2) . There is reason to believe that the streptococcal toxin causing these effects is similar to, if not identical with streptolysin O, the oxygen-labile hemolysin of streptococci. Proof of identity must await preparation of the material in pure form. Consideration of the above findings raises the question of whether the injection of streptococcal toxin into animals produces an effect comparable with that observed using the isolated frog's heart, namely, the release of a toxin inhibitor. Assuming that the tissues of an animal respond to the toxin by releasing into the circulation an inhibitor, two possibilities present themselves: (1) The inhibitor remains in the circulation causing the animal to become refractory to the subsequent injection of a dose of toxin lethal for normal members of the species. (2) The release of inhibitor is followed by its removal from the blood stream, and by analogy with the isolated frog's heart, the animal would become more susceptible than normal to the lethal effect of the toxin.
It follows that the injection of a sublethal dose of toxin into mice should either increase or decrease their susceptibility to a second injection of toxin.
Preliminary experiments designed to demonstrate decreased susceptibility were positive while experiments in which the other alternative was tested were negative. The experiments demonstrating the existence of a temporary refractory state in mice following the injection of a sublethal dose of toxin are described in this communication.
Methods and Materials
The smooth variant of the C203 strain of Streptococcus pyogenes was employed. Concentrates of the hemolysin-containing fraction of culture supernates were prepared according to the method previously described (1) with slight modifications. A single batch of toxin (No. 783) I was employed in all the experiments, and following the practice used in previous reports it is referred to as SPA (streptococcal preparation A). Unless otherwise indicated, the SPA was activated with an equal volume of 1 per cent cysteine for 10 minutes at room temperature at pH 6.8 to 7.0. The activated SPA was diluted with sterile saline to the desired volume prior to injection into mice. Swiss albino mice, strain CFW, weighing 1,6 to 20 gin., were employed. The SPA and other solutions used were diluted in sterile saline solution to a final volume of 0.4 cc. per mouse. Unless otherwise noted, all injections were intravenous.
EXPERIMENTAL
Mortality Rate as a Function of Dose.--In order to observe the effect of the dose on the mortality rate, various amounts of SPA were injected into groups of mice. A total of 56 mice was used in this experiment. The results are shown in Fig. 1 from which it can be seen that the LD~0 is 0.015 cc. of SPA. Unless otherwise indicated, mice that died within 3 hours were counted as deaths; all others as survivals. Although all mice were observed for a period of at least 72 hours, the 3 hour death time was selected because delay in death beyond this time did not commonly occur. Twenty-one hours later the mice received a second or "challenge" dose of 0.02 cc. of SPA. The mortality rate was 7/22 or 32 per cent. The mortality rate of 24 mice receiving 0.02 cc. of SPA, but which had not received a preliminary injection of SPA was 17/24 or 71 per cent. This experiment has been repeated on 4 occasions with similar results (Table I, part A). The average mortality rates of the 4 experiments were 29 per cent for 80 experimental mice, and 89 per cent for 62 control mice. The results show that the injection of a sublethal dose of SPA conferred a significant degree of resistance to the lethal effect of the SPA.
Induction of Resistance to the
In the course of experiments which extended over a period of several months, * The glutamine used in the cultivation of the streptococci was generously supplied by Lederle Laboratories, Inc.
there occurred some variation in the mortality rate produced by a constant dose of toxin. The variation was presumably due to differences in the susceptibility of different lots of mice or to slight changes in potency incurred in the preparaion of the dialyzed SPA. In order to eliminate this source of error, a dose which killed 66 to 100 per cent of untreated mice was always employed as the challenge dose. The prelimluary or sublethal dose, in every case was onefourth as large as the challenge dose. It is probable that the size of the first dose is critical for the production of the refractory state. Incidental observations suggest that resistance to the toxin fails to develop when the first dose is less than 1/4 to 1/6 the challenge dose.
The decreased the susceptibility of mice to a second injection of the same material, it was considered of interest to study the refractory state as a function of time.
Groups of mice were injected with a sublethal dose, and challenged after the following intervals of time: 0.5, 3, 6, 12, 21, 28, and 40 hours. The mortality rates of these and of corresponding control groups of mice are shown in Table  I , part B. The development of resistance is delineated by plotting against time the mortality rate of experimental mice divided by the mortality rate of control mice (Fig. 2) . The results show that resistance sets in between 3 and 6 hours, persists until the 28th hour, and disappears by the 40th hour.
Nature of the Refractory State and Specificity of Its Induction.--It is evident
from the time relationships that the toxin-induced protection is not due to antibody formation in the usual sense of the term. As a rule antibodies are not detectable until 40 to 50 hours after the first time an animal has been exposed to a given antigen. It is notable that the SPA-induced protection appears in approximately 1/10 this time. Although the rapidity of the response is comparable with that of an anamnestic reaction, a specific anamnestic response would seem to be ruled out by the temporary nature of the protection as well as by failure of unactivated toxin to stimulate protection (Table II) .
The work of Dougherty, Chase, and White (3) suggests that the mechanism of the non-specific anamnestic response involves the liberation of preformed 
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antibodies from lymphocytes, the release occurring through the operation of a hormonal mechanism. The results of these investigators led us to test adrenal cortical extract and benzene for their capacity to induce refractoriness, the latter having been shown to bring into play the necessary endocrine response. Both agents failed to induce the refractory state (Table II) . The results indicate that refractoriness depends upon neither newly formed nor preformed antibody.
Specificity of the Refractory State.--A series of experiments were conducted
in order to find out whether the resistance induced by SPA was directed only toward SPA or to other toxic agents as well. For the most part, agents were chosen which were cardiotoxic and hemolytic and therefore had pharmacological activity more or less similar to that of SPA. Since the refractory state lasts only 30 to 40 hours it was necessary to choose agents that produced death within a few hours after injection of small doses. The dose of each agent killing between 50 and 100 per cent of normal mice was determined. This amount of each agent was injected into normal mice and into mice prepared by a preliminary injection of the standard sublethal dose of SPA. The mortality rates and survival times of the various groups of mice are shown in Table ILl .
Inspection of Table III no difference in the mortality rates of normal mice and treated mice, the latter, when challenged with alpha toxin, survived somewhat longer than normal mice. The findings indicate that the refractoriness developing in mice injected with streptococcal toxin is in general directed specifically against the homologous toxin. However, as shown in the subsequent section, cross-refractoriness occurs with saponin.
Experiments Using Saponin.--A curious and unexpected relationship was revealed when mice injected with a sublethal dose of SPA were later challenged with a lethal dose of saponin. Mice treated in this way exhibited a degree of refractoriness to saponin comparable to that which had been found to develop against SPA itself (Table III) . It is apparent, therefore, that the protective mechanism is effective against both saponin and SPA. Experiments were then carried out to determine whether a sublethal dose of saponin confers protection against a lethal dose of saponin, and also whether resistance to SPA can be induced by the injection of a sublethal dose of saponin. Forty mice were injected with 0.1 rag. saponin. Twenty hours later, half of these mice were challenged with 0.23 rag. saponin and half with 0.028 cc. of SPA. Only 2 of the 20 mice which had been pretreated with saponin were killed by 0.25 rag. saponin while all of 20 normal mice were killed by 0.23 rag. saponin. Of the 20 mice which were pretreated with saponin and challenged with SPA, 80 per cent died as compared with 100 per cent of normal mice. However, as Table III shows, 75 per cent of the pretreated mice survived longer than 1 hour while 100 per cent of the normal mice survived less than 15 minutes. In summary, the results show that a sublethal dose of either SPA or saponin induces refractoriness to the effect of a lethal dose of either SPA or saponin. The results of experiments in which the cardiotoxic actions of SPA and saponin were compared, form the subject of a separate communication (5) . DISCUSSION Following the injection of a sublethal dose of a toxic preparation from Streptococcus pyogenes, there develops in mice a state of increased resistance to the lethal effect of the preparation. The increased resistance is characterized by three features: (1) The resistance manifests itself quickly (3 to 6 hours) and is of temporary duration (30 hours). (2) The degree of protection is relatively small. (3) The refractoriness exhibits a considerable degree of specificity.
The development of resistance in animals following exposure to injury has been repeatedly described in connection with investigations of the physiological and pharmacological effects of a wide variety of chemical and physical agents. Many of these observations have been reviewed in connection with what has been termed "the alarm reaction" which is said to be part of a "general adaptation syndrome" (6) . The alarm reaction is defined as "the sum of all nonspecific systemic phenomena elicited by sudden exposure to stimuli to which the organism is quantitatively or qualitatively not adapted." The refractory state which we have studied is relatively specific. Whether or not it depends upon "non-specific systemic phenomena," we cannot say. So far as we are aware, resistance of the type described in this report has seldom been observed in connection with bacterial toxins.
A temporarily increased resistance of pigeons to the effect of a lethal dose of the venom of Crotalus adarnanteus has been described by Kyes, Markin, and Graham (7). The increased resistance was induced by the injection of a sublethal dose of the venom. The similarity in time relationships and the degree of resistance described by these authors suggest that the refractoriness observed by them in pigeons and that observed by us in mice may depend upon comparable physiological processes.
The mechanism underlying the development of the refractory state is obscure. It was considered worthwhile to compare the erythrocytes of normal mice with those of refractory mice for sensitivity to the hemolytic action of SPA, particularly in view of the fact that increased resistance of erythrocytes to lysis is said (8) to follow the injection of certain hemolytic agents. No difference was found between the sensitivity to SPA of erythrocytes of normal mice and erythrocytes of refractory mice. Similarly, the autihemolytic action of plasma of normal mice was found to be no less than that of the plasma of refractory mice. As was pointed out in the introduction, the experiments with mice were undertaken in anticipation of the possibility that exposure of mice to a sublethal dose of SPA might give rise to the appearance of an SPA inhibitor in the blood stream. Although the findings can be explained by assuming that an SPA inhibitor is present in the circulating blood, experiments designed to reveal the presence of the inhibitor have been negative. It is possible that the increase in resistance reflects changes in the state of the serum lipids and that the tests thus far performed are not adequate to detect such changes. In this connection, it is notable that the toxic actions of both SPA (1) and saponin (9) are inhibited by cholesterol. There also remains the possibility that the refractoriness is not due to a humoral mechanism at all, but depends upon a lessened sensitivity of the tissues of the heart or other organs upon which the toxin acts.
The chief implications of the findings reported are: (a) there exists in the mouse an "antitoxic" mechanism which is dependent upon processes distinct from those commonly accepted as underlying immunological phenomena; (b) the mode of action of saponin and streptococcal toxin may be fundamentally similar.
It would be of interest to know whether bacterial toxins other than those investigated can also induce refractoriness, and whether other species of mammals are capable of developing resistance comparable in specificity to that shown by the mouse.
1. The susceptibility of mice to the lethal effect of preparations containing the oxygen-labile hemolysin (streptolysin O) of group A hemolytic streptococci has been studied. Injection of a single sublethal dose of the streptococcal preparation causes the development of resistance to the effect of a lethal dose injected subsequently.
2. Resistance is demonstrable 3 to 6 hours after the injection of the streptococcal preparation, persists for approximately 30 hours, and then disappears.
3. Resistance induced by the streptococcal preparation, although relatively specific, is directed not only against the streptococcal preparation but also against saponin. Mice made refractory to the streptococcal preparation and to saponin exhibit normal susceptibility to a number of other toxic agents, with the possible exception of the alpha toxin of Cl. welchii.
4. Mice iniected with a sublethal dose of saponin develop resistance to the effect of a lethal dose of either saponin or the streptococcal preparation.
5. Resistance depends upon processes distinct from those underlying classical antitoxic immunity.
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